Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Kramer

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Cancer|January 8, 2005
Five-day courses of irinotecan as palliative therapy for patients with neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Irinotecan plus temozolomide for relapsed or refractory neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Journal of Pediatric Hematology/Oncology|July 9, 2003
Curability of recurrent disseminated disease after surgery alone for local-regional neuroblastoma using intensive chemotherapy and anti-G(D2) immunotherapyBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
Journal of Pediatric Hematology/Oncology|January 7, 2004
Radically different treatment recommendations for newly diagnosed neuroblastoma: pitfalls in assessment of riskBrian H Kushner, Michael P LaQuaglia, Kim Kramer, et al.
Cancer|June 17, 2006
Ototoxicity from high-dose use of platinum compounds in patients with neuroblastomaBrian H Kushner, Amy Budnick, Kim Kramer, et al.
Pediatric Blood & Cancer|July 12, 2017
Central nervous system relapse of rhabdomyosarcomaBrian De, Michael D Kinnaman, Leonard H Wexler, et al.
International Journal of Cancer|July 16, 2025
Rapid COJEC without myeloablative therapy for high-risk neuroblastomaBrian H Kushner, Ellen M Basu, Fiorella Iglesias Cardenas, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pediatric Blood & Cancer|August 28, 2009
A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapyBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Cancer|January 8, 2005
Five-day courses of irinotecan as palliative therapy for patients with neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Irinotecan plus temozolomide for relapsed or refractory neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Journal of Pediatric Hematology/Oncology|July 9, 2003
Curability of recurrent disseminated disease after surgery alone for local-regional neuroblastoma using intensive chemotherapy and anti-G(D2) immunotherapyBrian H Kushner, Kim Kramer, Michael P LaQuaglia, et al.
Journal of Pediatric Hematology/Oncology|January 7, 2004
Radically different treatment recommendations for newly diagnosed neuroblastoma: pitfalls in assessment of riskBrian H Kushner, Michael P LaQuaglia, Kim Kramer, et al.
Cancer|June 17, 2006
Ototoxicity from high-dose use of platinum compounds in patients with neuroblastomaBrian H Kushner, Amy Budnick, Kim Kramer, et al.
Pediatric Blood & Cancer|July 12, 2017
Central nervous system relapse of rhabdomyosarcomaBrian De, Michael D Kinnaman, Leonard H Wexler, et al.
International Journal of Cancer|July 16, 2025
Rapid COJEC without myeloablative therapy for high-risk neuroblastomaBrian H Kushner, Ellen M Basu, Fiorella Iglesias Cardenas, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pediatric Blood & Cancer|August 28, 2009
A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapyBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pageof 11